ProKidney Corp.
PROK · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| R&D Expenses | $128 | $107 | $82 | $46 |
| G&A Expenses | $56 | $45 | $71 | $9 |
| SG&A Expenses | $56 | $45 | $71 | $9 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $184 | $152 | $153 | $55 |
| Operating Income | -$184 | -$152 | -$153 | -$55 |
| % Margin | -241,678.9% | – | – | – |
| Other Income/Exp. Net | $20 | $22 | $6 | $0 |
| Pre-Tax Income | -$164 | -$129 | -$147 | -$55 |
| Tax Expense | -$1 | $6 | $1 | $0 |
| Net Income | -$61 | -$35 | -$108 | -$55 |
| % Margin | -80,507.9% | – | – | – |
| EPS | -0.62 | -0.57 | -1.76 | -1.73 |
| % Growth | -8.8% | 67.6% | -1.7% | – |
| EPS Diluted | -0.62 | -0.57 | -1.76 | -1.73 |
| Weighted Avg Shares Out | 98 | 62 | 62 | 32 |
| Weighted Avg Shares Out Dil | 98 | 62 | 62 | 32 |
| Supplemental Information | – | – | – | – |
| Interest Income | $20 | $22 | $6 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $5 | $4 | $3 | $2 |
| EBITDA | -$158 | -$126 | -$144 | -$53 |
| % Margin | -208,542.1% | – | – | – |